Veterinary Medicines

CEVAC CLOSTRIDIUM OVINO

Authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type C, beta1 toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, type A, alpha toxoid
Download as PDF

Product identification

Medicine name:
PANCLOSTIL-S ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
CEVAC CLOSTRIDIUM OVINO
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type C, beta1 toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium perfringens, type A, alpha toxoid
Target species:
  • Sheep (lamb)
  • Sheep (pregnant ewe)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    2.20
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type C, beta1 toxoid
    20.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    5.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium tetani, toxoid
    5.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    100.00
    percentage protection
    /
    2.00
    millilitre(s)
  • Clostridium novyi, type B, alpha toxoid
    7.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    90.00
    percentage protection
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type A, alpha toxoid
    1.10
    international unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Sheep (pregnant ewe)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • box containing 1 vial of 250 ml
  • box containing 1 vial of 100 ml
  • box containing 1 vial of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Hellas LLC
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cz Veterinaria S.A.
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 8834/12/22-02-2013/K-0170801
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0120/001
Concerned member states:
  • Greece
  • Italy

Documents

Combined File of all Documents

English (PDF)
Published on: 30/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."